神経血管デバイス市場規模、シェア、成長分析：疾患病理別、エンドユーザー別、地域別 - 産業予測 2025～2032年

神経血管デバイス市場規模は2023年に37億米ドルと評価され、2024年の40億1,000万米ドルから2032年には77億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.5％で成長する見通しです。

世界の神経血管デバイス市場は、神経疾患や心血管疾患の罹患率の上昇に牽引されて大きな成長を遂げています。人口の高齢化と神経血管障害を取り巻く意識の高まりが、これらのデバイスの需要をさらに促進しています。加えて、低侵襲手術へのシフト、医療機器の技術進歩、早期診断への注目は市場拡大を促進すると予想されます。急性虚血性脳卒中の発生率の高さは、世界中の機器メーカーに新たな機会をもたらしています。しかし、神経血管デバイスの高コスト、厳しい規制の枠組み、新興国市場でのアクセス制限、潜在的な合併症などの課題が、長期的な市場開拓の妨げになる可能性があります。全体として、同市場は有望な成長ポテンシャルを有するもの、その見通しを最大化するためにはこれらの障害を乗り越える必要があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 特許分析
• ケーススタディ
• 顧客と購買基準の分析
• 貿易分析

神経血管デバイス市場規模：疾患病理別 & CAGR（2025-2032）

• 市場概要
• 脳動脈瘤
  • 塞栓コイル
  • 取り外し可能な裸コイル
  • コーティングされた取り外し可能なコイル
  • 流れ転換装置
  • 頭蓋内ステント
  • マイクロカテーテル
  • ガイドワイヤー
• 虚血性脳卒中
  • 血栓除去装置
  • 吸引・吸引装置
  • 血管スネア
  • マイクロカテーテル
  • マイクロガイドワイヤー
  • バルーンカテーテル
• 頸動脈狭窄症
  • 頸動脈ステント
  • 塞栓保護デバイス
  • バルーンカテーテル
• 動静脈奇形および瘻孔
  • 液体塞栓剤
  • 閉塞バルーンカテーテル
  • マイクロカテーテル
• その他の疾患の病理

神経血管デバイス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院と外科センター
• 外来診療センター
• 調査室と学術機関

神経血管デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Acandis GmbH（Germany）
• Asahi Intecc Co. Ltd.（Japan）
• Imperative Care Inc.（United States）
• Integer Holdings Corporation（United States）
• Johnson & Johnson（United States）
• Medtronic plc（Ireland）
• MicroPort Scientific Corporation（China）
• Penumbra Inc.（United States）
• Perflow Medical Ltd.（Israel）
• Rapid Medical（Canada）
• Stryker Corporation（United States）
• Terumo Corporation（Japan）
• WL Gore & Associates（United States）
• Penumbra, Inc.（United States）（duplicate）
• Siemens Healthineers AG（Germany）
• Boston Scientific Corporation（United States）
• InspireMD, Inc.（Israel）

結論と提言

Neurovascular Devices Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.01 billion in 2024 to USD 7.71 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The global neurovascular devices market is witnessing significant growth driven by the rising incidence of neurological disorders and cardiovascular diseases. An aging population and increased awareness surrounding neurovascular disorders further propel demand for these devices. Additionally, the shift toward minimally invasive surgeries, technological advancements in medical devices, and a focus on early diagnosis are expected to enhance market expansion. High rates of acute ischemic stroke present new opportunities for device suppliers worldwide. However, challenges such as the high cost of neurovascular devices, stringent regulatory frameworks, limited access in developing regions, and potential complications may hinder long-term market development. Overall, while the market has promising growth potential, it must navigate these obstacles to maximize its outlook.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Devices Market Segments Analysis

Global Neurovascular Devices Market is segmented by Disease Pathology, End User and region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, Arteriovenous Malformation & Fistulas and Other Disease Pathologies. Based on End User, the market is segmented into Hospitals And Surgical Centers, Ambulatory Care Centers and Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Devices Market

The rising prevalence of neurovascular diseases, attributed to poor lifestyle choices and the widespread adoption of unhealthy habits, has led to a dramatic increase in the number of individuals affected by conditions like strokes and cerebral aneurysms globally. This growing incidence of neurovascular conditions is a significant driver fueling the demand for neurovascular devices. As more people seek medical interventions and solutions to address these escalating health issues, the market for neurovascular devices is expected to expand, providing opportunities for innovation and development in treatments aimed at managing and preventing such critical health challenges.

Restraints in the Neurovascular Devices Market

The Neurovascular Devices market faces a significant challenge due to the exorbitant costs associated with these advanced medical technologies. While developed countries may manage these expenses, healthcare institutions in developing nations often operate within constrained budgets, hindering their ability to procure such specialized devices. This financial barrier limits access to essential treatments and innovations in neurovascular care, potentially exacerbating healthcare disparities between different regions. As a result, the high costs of these devices may restrict their widespread adoption, ultimately impeding advancements in patient care and outcomes in less affluent healthcare systems.

Market Trends of the Neurovascular Devices Market

The Neurovascular Devices market is witnessing a significant shift towards the development of minimally invasive technologies, driven by a global preference for procedures that offer quicker recovery times and enhanced patient comfort. As healthcare professionals and patients increasingly seek alternatives to traditional surgical techniques, manufacturers are strategically investing in the innovation of neurovascular devices that facilitate less invasive interventions. This trend not only enhances treatment efficacy but also addresses the burgeoning demand for efficient healthcare solutions. Consequently, companies focusing on the advancement of minimally invasive neurovascular devices are likely to experience substantial sales growth and improve their competitive positioning in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Trade Analysis

Global Neurovascular Devices Market Size by Disease Pathology & CAGR (2025-2032)

• Market Overview
• Cerebral Aneurysms
  • Embolic Coils
  • Bare Detachable Coils
  • Coated Detachable Coils
  • Flow Diversion Devices
  • Intracranial Stents
  • Microcatheters
  • Guidewires
• Ischemic Strokes
  • Clot Retriever Devices
  • Suction & Aspiration Devices
  • Vascular Snares
  • Microcatheters
  • Microguidewires
  • Balloon Catheters
• Carotid Artery Stenosis
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Balloon Catheters
• Arteriovenous Malformation & Fistulas
  • Liquid Embolic Agents
  • Occlusion Balloon Catheters
  • Microcatheters
• Other Disease Pathologies

Global Neurovascular Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals And Surgical Centers
• Ambulatory Care Centers
• Research Laboratories and Academic Institutes

Global Neurovascular Devices Market Size & CAGR (2025-2032)

• North America (Disease Pathology, End User)
  • US
  • Canada
• Europe (Disease Pathology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Pathology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Pathology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Pathology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imperative Care Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perflow Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WL Gore & Associates (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (United States) (duplicate)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InspireMD, Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations